Group One Trading’s Checkpoint Therapeutics CKPT Stock Holding History

Group One Trading’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-25,632	Closed	-$104K	–	8001
2025 Q1	$104K	Buy	25,632 +20,727	+423%	+$69.1K	﹤0.01%	4575
2024 Q4	$15.7K	Buy	+4,905	New	+$16.6K	﹤0.01%	5847
2023 Q3	–	Sell	-3,719	Closed	-$8.45K	–	7700
2023 Q2	$9.19K	Buy	+3,719	New	+$10.2K	﹤0.01%	6440
2023 Q1	–	Sell	-4,602	Closed	-$23.1K	–	7276
2022 Q4	$23.5K	Sell	4,602 -1,277	-22%	-$9.2K	﹤0.01%	5504
2022 Q3	$61K	Sell	5,879 -4,240	-42%	-$50.5K	﹤0.01%	5228
2022 Q2	$104K	Sell	10,119 -7,445	-42%	-$97.5K	﹤0.01%	4946
2022 Q1	$311K	Buy	+17,564	New	+$377K	﹤0.01%	4335
2021 Q4	–	Sell	-10	Closed	-$331	–	8266
2021 Q3	$0	Buy	+10	New	+$296	﹤0.01%	8217

Group One Trading's CKPT Position: Q2 2025 in Review

Group One Trading sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 25,632 shares — an estimated $104K sold.

Group One Trading first reported a position in CKPT in Q3 2021 and held it in 8 quarters. The position peaked at $311K in Q1 2022. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Group One Trading reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Group One Trading sold 25,632 Checkpoint Therapeutics shares in Q2 2025, an estimated $104K.
Group One Trading first reported a position in Checkpoint Therapeutics in Q3 2021 and held it in 8 quarters.
Group One Trading's Checkpoint Therapeutics position peaked at $311K in Q1 2022.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.